These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15744089)

  • 1. Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro.
    Yamasaki K; Kuga N; Takamura N; Furuya Y; Hidaka M; Iwakiri T; Nishii R; Okumura M; Kodama H; Kawai K; Arimori K
    Biol Pharm Bull; 2005 Mar; 28(3):549-52. PubMed ID: 15744089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
    Kasai S; Horie T; Mizuma T; Awazu S
    J Pharm Sci; 1987 May; 76(5):387-92. PubMed ID: 3656100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
    Basken NE; Mathias CJ; Green MA
    J Pharm Sci; 2009 Jun; 98(6):2170-9. PubMed ID: 18937368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site.
    Thumser AE; Buckland AG; Wilton DC
    J Lipid Res; 1998 May; 39(5):1033-8. PubMed ID: 9610770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial relationship between the prodan site, Trp-214, and Cys-34 residues in human serum albumin and loss of structure through incremental unfolding.
    Krishnakumar SS; Panda D
    Biochemistry; 2002 Jun; 41(23):7443-52. PubMed ID: 12044178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T; Takamura N; Nishii R; Tokunaga J; Yoshimoto M; Kawai K
    Nephrol Dial Transplant; 2008 Jul; 23(7):2304-10. PubMed ID: 18390890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-binding relationship and binding sites of cephalosporins in human serum albumin.
    Tawara S; Matsumoto S; Matsumoto Y; Kamimura T; Goto S
    J Antibiot (Tokyo); 1992 Aug; 45(8):1346-57. PubMed ID: 1399856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Alkylaminocoumarin-4-acetic acids as fluorescent probe for studies of drug-binding sites on human serum albumin.
    Irikura M; Takadate A; Goya S; Otagiri M
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):724-8. PubMed ID: 2070455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of pressure-induced denatured state of human serum albumin: a comparison with the intermediate in urea-induced denaturation.
    Tanaka N; Nishizawa H; Kunugi S
    Biochim Biophys Acta; 1997 Mar; 1338(1):13-20. PubMed ID: 9074611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
    Anguizola J; Debolt E; Suresh D; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase.
    Noctor TA; Wainer IW; Hage DS
    J Chromatogr; 1992 Jun; 577(2):305-15. PubMed ID: 1400761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug binding sites on chicken albumin: a comparison to human albumin.
    Rajaian H; Symonds HW; Bowmer CJ
    J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disaccharide anthracycline MEN 10755 binds human serum albumin to a non-classical drug binding site.
    Messori L; Piccioli F; Gabrielli S; Orioli P; Angeloni L; Di Bugno C
    Bioorg Med Chem; 2002 Nov; 10(11):3425-30. PubMed ID: 12213455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.
    Frostell-Karlsson A; Remaeus A; Roos H; Andersson K; Borg P; Hämäläinen M; Karlsson R
    J Med Chem; 2000 May; 43(10):1986-92. PubMed ID: 10821711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do fatty acids cause allosteric binding of drugs to human serum albumin?
    Chuang VT; Otagiri M
    Pharm Res; 2002 Oct; 19(10):1458-64. PubMed ID: 12425462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined fluorescence and electrochemical investigation on the binding interaction between organic acid and human serum albumin.
    Chen YM; Guo LH
    J Environ Sci (China); 2009; 21(3):373-9. PubMed ID: 19634451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.